Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease-Reference-Cited by-同舟云学术

Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease

Published:2014-11-11 Issue:18 Volume:74 Page:2175-2190
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Frampton James E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-014-0322-5.pdf

Reference56 articles.

1. Löhle M, Ramberg CJ, Reichmann H, et al. Early versus delayed initiation of pharmacotherapy in Parkinson’s disease. Drugs. 2014;74(6):645–57.

2. Chaudhuri KR, Healy DG, Schapira AH, et al. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol. 2006;5(3):235–45.

3. Sprenger F, Poewe W. Management of motor and non-motor symptoms in Parkinson’s disease. CNS Drugs. 2013;27(4):259–72.

4. European Parkinson’s Disease Association. Prevalence of Parkinson’s disease. 2014. http://www.epda.eu.com/en/parkinsons/life-with-parkinsons/part-1/prevalence-of-parkinsons-disease/ . Accessed 10 July 2014.

5. Perez-Lloret S, Rascol O. Dopamine receptor agonists for the treatment of early or advanced Parkinson’s disease. CNS Drugs. 2010;24(11):941–68.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging Pharma and Sustainability: Green Electrochemical Analysis of Antiparkinsonian Drug in Pharmaceuticals and Plasma, Aligned with United Nations Goals via the NQS Index;Journal of The Electrochemical Society;2024-07-01

2. Computer-Aided Design and Biological Evaluation of Diazaspirocyclic D₄R Antagonists;ACS Chemical Neuroscience;2024-06-07

3. A Systematic Review and Meta-Analysis of the Efficacy and Safety of Rasagiline or Pramipexole in the Treatment of Early Parkinson’s Disease;Parkinson's Disease;2024-01-16

4. Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial;Drug Design, Development and Therapy;2023-08

5. Formulation and in vitro evaluation of pramipexole orally disintegrating tablets for pediatric restless leg syndrome;Journal of Research in Pharmacy;2023